1. Aldridge, K. E., Sanders, C. V., Marier, R. L. Variation in the potentiation of beta-lactam antibiotic activity by clavulanic acid and sulbactam against multiply antibiotic-resistant bacteria. J. Antimicrob. Chemother. 17 (1986) 463–469.
2. Christensen, G. D., Simpson, W. A., Bisno, A. L., Beachey, E. H. Adherence of slime-producing strains ofStaphylococcus epidermidis to smooth surfaces. Infect. Immun. 37 (1982) 318–326.
3. English, A. R., Retsema, J. A., Girard, A. E., Lynch, J. E., Barth, W. E. CP-45, 899, a beta-lactamase inhibitor that extends the antibacterial spectrum of beta-lactams: initial bacteriological characterization. Antimicrob. Agents Chemother. 14 (1978) 414–419.
4. Grimm, H.: Thein vitro activity of sulbactam/ampicillin. In:Ueda, Y., Neu, H. C. (eds.): Beta-lactamase blocking agents. Proceedings of a workshop held at the 14th International Congress of Chemotherapy, Kyoto, Japan 1985, University of Tokyo Press, 1986, pp. 19–24.
5. Retsema, J. A., English, A. R., Girard, A. E., Anderson, M., Brennan, L., Cimochowski, C., Faiella, J., Herbert, C.: Sulbactam and ampicillin: synergistic antibacterial activity against hospital isolates of Enterobacteriaceae, methicillin-resistantStaphylococcus, and anaerobes. Proceedings of the 13th International Congress of Chemotherapy, Vienna, Austria, 1983, 23/1–23/5.